Chugai Pharmaceutical Co., Ltd. (CHGCF)
54.79
+3.92
(+7.71%)
USD |
OTCM |
Dec 11, 16:00
Chugai Pharmaceutical EPS Diluted (Quarterly): 0.4582 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0253 |
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 754.13M |
| Revenue (Quarterly) | 2.259B |
| Total Expenses (Quarterly) | 1.505B |
| Enterprise Value | 84.27B |
| Gross Profit Margin (Quarterly) | 69.91% |
| Profit Margin (Quarterly) | 33.38% |
| Earnings Yield | 2.96% |
| Operating Earnings Yield | 4.33% |
| Normalized Earnings Yield | 3.148 |